Opposite effects of single-dose and multidose administration of the ethanol extract of danshen on CYP3A in healthy volunteers

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Qiu, Furong ^a   Jiang, Jian ^a   Ma, Yueming ^a   Wang, Guangji ^b   Gao, Chenglu ^a   Zhang, Xinfeng ^a   Zhang, Liang ^a   Liu, Songcan ^a   He, Min ^a   Zhu, Leilei ^a   Ye, Yujie ^a   Li, Qiuye ^a   Miao, Ping ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HYDROXYMIDAZOLAM; CRYPTOTANSHINONE; CYTOCHROME P450 3A; MIDAZOLAM; SALVIA MILTIORRHIZA EXTRACT; TANSHINONE IIA;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE COMPARISON; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MALE; NORMAL HUMAN; OPEN STUDY; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT DURATION;

EID: 84886715691     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/730734     Document Type: Article

References (27)

1. Cheng T. O., Danshen: a popular chinese cardiac herbal drug. Journal of the American College of Cardiology 2006 47 7 1498 1499 2-s2.0-33645402536 10.1016/j.jacc.2006.01.001
2. Cheng T. O., Cardiovascular effects of Danshen. International Journal of Cardiology 2007 121 1 9 22 2-s2.0-34548079309 10.1016/j.ijcard.2007.01.004 (Pubitemid 47287779)
3. Lee J. H., Shin Y.-J., Kim H. J., Oh J.-H., Jang Y. P., Lee Y.-J., Danshen extract does not alter pharmacokinetics of docetaxel and clopidogrel, reflecting its negligible potential in P-glycoprotein- and cytochrome P4503A-mediated herb-drug interactions. International Journal of Pharmaceutics 2011 410 1-2 68 74 2-s2.0-79955603019 10.1016/j.ijpharm.2011.03.031
4. Xu Y. Y., Wan R. Z., Lin Y. P., Yang L., Chen Y., Liu C. X., Recent advance on reseach and application of Salvia miltiorrhiza. Asian Journal of Drug Metabolism and Pharmacokinetics 2007 7 99 130
5. Zhou W., Ruigrok T. J. C., Protective effect of Danshen during myocardial ischemia and reperfusion: an isolated rat heart study. American Journal of Chinese Medicine 1990 18 1-2 19 24 2-s2.0-0025081050 (Pubitemid 20356928)
6. Ji X.-Y., Tan B. K.-H., Zhu Y.-Z., Salvia miltiorrhiza and ischemic diseases. Acta Pharmacologica Sinica 2000 21 12 1089 1094 2-s2.0-0034534954 (Pubitemid 32012715)
7. Kuo Y.-H., Lin Y.-L., Don M.-J., Chen R.-M., Ueng Y.-F., Induction of cytochrome P450-dependent monooxygenase by extracts of the medicinal herb Salvia miltiorrhiza. Journal of Pharmacy and Pharmacology 2006 58 4 521 527 2-s2.0-33645564707 10.1211/jpp.58.4.0012
8. Yu C., Ye S., Sun H., Liu Y., Gao L., Shen C., Chen S., Zeng S., PXR-mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIA. Chemico-Biological Interactions 2009 177 1 58 64 2-s2.0-57349177645 10.1016/j.cbi.2008.08.013
9. Wang X., Cheung C. M., Lee W. Y. W., Or P. M. Y., Yeung J. H. K., Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro. Phytomedicine 2010 17 11 868 875 2-s2.0-77955983219 10.1016/j.phymed.2010.05.003
10. Bjornsson T. D., Callaghan J. T., Einolf H. J., Fischer V., Gan L., Grimm S., Kao J., King S. P., Miwa G., Ni L., Kumar G., McLeod J., Obach S. R., Roberts S., Roe A., Shah A., Snikeris F., Sullivan J. T., Tweedie D., Vega J. M., Walsh J., Wrighton S. A., The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective. Journal of Clinical Pharmacology 2003 43 5 443 469 2-s2.0-0142131213 (Pubitemid 36506147)
11. Hao H., Wang G., Cui N., Li J., Xie L., Ding Z., Pharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersion. Planta Medica 2006 72 14 1311 1317 2-s2.0-33845254587 10.1055/s-2006-951698 (Pubitemid 44862033)
12. Hao H., Wang G., Li P., Li J., Ding Z., Simultaneous quantification of cryptotanshinone and its active metabolite tanshinone IIA in plasma by liquid chromatography/tandem mass spectrometry (LC-MS/MS). Journal of Pharmaceutical and Biomedical Analysis 2006 40 2 382 388 2-s2.0-31344462935 10.1016/j.jpba.2005.07.029 (Pubitemid 43143343)
13. Zhou L., Chow M., Zuo Z., Improved quality control method for Danshen products-consideration of both hydrophilic and lipophilic active components. Journal of Pharmaceutical and Biomedical Analysis 2006 41 3 744 750 2-s2.0-33646417027 10.1016/j.jpba.2005.12.032
14. Qiu F., Zhang R., Sun J., Jiye A., Hao H., Peng Y., Ai H., Wang G., Inhibitory effects of seven components of danshen extract on catalytic activity of cytochrome P450 enzyme in human liver microsomes. Drug Metabolism and Disposition 2008 36 7 1308 1314 2-s2.0-46449109055 10.1124/dmd.108.021030 (Pubitemid 351929315)
15. Garrett M., Smeraglia J., Lin X., Tan L., Tran J., A pilot study to assess simultaneous administration of oral midazolam (MDZ) and fexofenadine (FEX) for the evaluation of cytochrome (CYP) 3A4 and P-glycoprotein (P-gp) activities. Clinical Pharmacology & Therapeutics 2005 77 45
16. Seo K.-A., Bae S. K., Choi Y.-K., Choi C. S., Liu K.-H., Shin J.-G., Metabolism of 1′- and 4-hydroxymidazolam by glucuronide conjugation is largely mediated by UDP-glucuronosyltransferases 1A4, 2B4, and 2B7. Drug Metabolism and Disposition 2010 38 11 2007 2013 2-s2.0-78049364078 10.1124/dmd.110.035295
17. Wu C.-Y., Benet L. Z., Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharmaceutical Research 2005 22 1 11 23 2-s2.0-17644380257 10.1007/s11095-004-9004-4 (Pubitemid 40558141)
18. Gorski J. C., Jones D. R., Haehner-Daniels B. D., Hamman M. A., O'Mara E. M. Jr., Hall S. D., The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. Clinical Pharmacology and Therapeutics 1998 64 2 133 143 2-s2.0-0031696409 10.1016/S0009-9236(98)90146-1 (Pubitemid 28423848)
19. Sakuda S., Akabane T., Teramura T., Marked species differences in the bioavailability of midazolam in cynomolgus monkeys and humans. Xenobiotica 2006 36 4 331 340 2-s2.0-33646818650 10.1080/00498250600571749
20. Qiu F., Zhang R., Wang G., Gao C., Sun J., Jiang J., Ma Y., Activation of CYP3A-mediated testosterone 6 β -hydroxylation by tanshinone IIA and midazolam 1-hydroxylation by cryptotanshinone in human liver microsomes. Xenobiotica 2010 40 12 800 806 2-s2.0-78249254285 10.3109/00498254.2010.519062
21. Fahmi O. A., Kish M., Boldt S., Obach R. S., Cytochrome P450 3A4 mRNA is a more reliable marker than CYP3A4 activity for detecting pregnane X receptor-activated induction of drug-metabolizing enzymes. Drug Metabolism and Disposition 2010 38 9 1605 1611 2-s2.0-77955999532 10.1124/dmd.110.033126
22. Qiu F., Wang G., Zhang R., Sun J., Jiang J., Ma Y., Effect of danshen extract on the activity of CYP3A4 in healthy volunteers. British Journal of Clinical Pharmacology 2010 69 6 656 662 2-s2.0-77952039173 10.1111/j.1365-2125. 2010.03624.x
23. Xie H. G., Kim R. B., St. John's wort-associated drug interaction: short-term inhibition and long-term induction. Clinical Pharmacology & Therapeutics 2005 73 41 50
24. Moore L. B., Parks D. J., Jones S. A., Bledsoe R. K., Consler T. G., Stimmel J. B., Goodwin B., Liddle C., Blanchard S. G., Willson T. M., Collins J. L., Kliewer S. A., Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. Journal of Biological Chemistry 2000 275 20 15122 15127 2-s2.0-0034685779 10.1074/jbc.M001215200 (Pubitemid 30337234)
25. El-Sankary W., Plant N. J., Gibson G. G., Moore D. J., Regulation of the CYP3A4 gene by hydrocortisone and xenobiotics: role of the glucocorticoid and pregnane X receptors. Drug Metabolism and Disposition 2000 28 5 493 496 2-s2.0-0010258751 (Pubitemid 30238506)
26. Pascussi J.-M., Drocourt L., Gerbal-Chaloin S., Fabre J.-M., Maurel P., Vilarem M.-J., Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor. European Journal of Biochemistry 2001 268 24 6346 6357 2-s2.0-0035659943 10.1046/j.0014-2956.2001.02540.x (Pubitemid 34014742)
27. Geick A., Eichelbaum M., Burk O., Nuclear receptor response elements mediate induction of intestinal MDR1 by Rifampin. Journal of Biological Chemistry 2001 276 18 14581 14587 2-s2.0-0035805536 10.1074/jbc.M010173200